Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
2.650
+0.140 (5.58%)
At close: Nov 20, 2024, 4:00 PM
2.810
+0.160 (6.04%)
After-hours: Nov 20, 2024, 5:54 PM EST
Impact BioMedical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 30 | - | - | - | - | - | |
Enterprise Value | 39 | - | - | - | - | - | |
Debt / Equity Ratio | 0.23 | 0.43 | 0.31 | 0.31 | 0.03 | - | |
Asset Turnover | - | - | 0.00 | - | - | - | |
Quick Ratio | 2.34 | 0.01 | 0.00 | 0.00 | 0.07 | 15.49 | |
Current Ratio | 2.79 | 0.03 | 0.01 | 0.02 | 0.10 | 19.86 | |
Return on Equity (ROE) | 3.45% | -14.47% | -19.99% | -4.52% | -3.89% | -1100.67% | |
Return on Assets (ROA) | -4.99% | -5.53% | -4.13% | -3.81% | -2.32% | -322.67% | |
Return on Capital (ROIC) | -5.47% | -6.07% | -4.47% | -4.18% | -2.61% | -550.85% | |
Buyback Yield / Dilution | 14.00% | 14.54% | -0.00% | - | - | - | |
Total Shareholder Return | 14.00% | 14.54% | -0.00% | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.